Global Over-The-Counter Drug Market 2023-2027

Description

List of Tables

Technavio has been monitoring the over-the-counter drug market and is forecast to grow by USD 58.54 bn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. Our report on the over-the-counter drug market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in the global over-the-counter drug market, the rising prevalence of diseases and otc drug use, and favorable regulatory framework for OTC drugs.

Technavio's over-the-counter drug market is segmented as below:

By Route Of Administration

Oral
Topical
Parenteral
Others

By Distribution Channel

Offline
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing geriatric population as one of the prime reasons driving the over-the-counter drug market growth during the next few years. Also, increasing healthcare expenditure and growing adoption of e-commerce platforms for otc drugs will lead to sizable demand in the market.

Over-the-counter drug market sizing
Over-the-counter drug market forecast
Over-the-counter drug market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over-the-counter drug market vendors that include Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Ltd., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.. Also, the over-the-counter drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Product Code: IRTNTR75281

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global over-the-counter drug market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration

6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Topical - Market size and forecast 2022-2027
Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
6.5 Parenteral - Market size and forecast 2022-2027
Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Route of Administration
Exhibit 50: Market opportunity by Route of Administration ($ billion)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ billion)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ billion)
Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Achelios Therapeutics Inc.
Exhibit 120: Achelios Therapeutics Inc. - Overview
Exhibit 121: Achelios Therapeutics Inc. - Product / Service
Exhibit 122: Achelios Therapeutics Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 123: AstraZeneca Plc - Overview
Exhibit 124: AstraZeneca Plc - Product / Service
Exhibit 125: AstraZeneca Plc - Key news
Exhibit 126: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 127: Bayer AG - Overview
Exhibit 128: Bayer AG - Business segments
Exhibit 129: Bayer AG - Key news
Exhibit 130: Bayer AG - Key offerings
Exhibit 131: Bayer AG - Segment focus
12.7 BioGaia AB
Exhibit 132: BioGaia AB - Overview
Exhibit 133: BioGaia AB - Business segments
Exhibit 134: BioGaia AB - Key news
Exhibit 135: BioGaia AB - Key offerings
Exhibit 136: BioGaia AB - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 137: Boehringer Ingelheim International GmbH - Overview
Exhibit 138: Boehringer Ingelheim International GmbH - Business segments
Exhibit 139: Boehringer Ingelheim International GmbH - Key news
Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bukwang Pharmaceutical Co. Ltd.
Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview
Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service
Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings
12.10 Chr Hansen Holding AS
Exhibit 145: Chr Hansen Holding AS - Overview
Exhibit 146: Chr Hansen Holding AS - Business segments
Exhibit 147: Chr Hansen Holding AS - Key news
Exhibit 148: Chr Hansen Holding AS - Key offerings
Exhibit 149: Chr Hansen Holding AS - Segment focus
12.11 CVS Health Corp.
Exhibit 150: CVS Health Corp. - Overview
Exhibit 151: CVS Health Corp. - Business segments
Exhibit 152: CVS Health Corp. - Key news
Exhibit 153: CVS Health Corp. - Key offerings
Exhibit 154: CVS Health Corp. - Segment focus
12.12 GlaxoSmithKline Plc
Exhibit 155: GlaxoSmithKline Plc - Overview
Exhibit 156: GlaxoSmithKline Plc - Business segments
Exhibit 157: GlaxoSmithKline Plc - Key news
Exhibit 158: GlaxoSmithKline Plc - Key offerings
Exhibit 159: GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Exhibit 160: Johnson and Johnson Services Inc. - Overview
Exhibit 161: Johnson and Johnson Services Inc. - Business segments
Exhibit 162: Johnson and Johnson Services Inc. - Key news
Exhibit 163: Johnson and Johnson Services Inc. - Key offerings
Exhibit 164: Johnson and Johnson Services Inc. - Segment focus
12.14 Novartis AG
Exhibit 165: Novartis AG - Overview
Exhibit 166: Novartis AG - Business segments
Exhibit 167: Novartis AG - Key offerings
Exhibit 168: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 169: Pfizer Inc. - Overview
Exhibit 170: Pfizer Inc. - Product / Service
Exhibit 171: Pfizer Inc. - Key news
Exhibit 172: Pfizer Inc. - Key offerings
12.16 Reckitt Benckiser Group Plc
Exhibit 173: Reckitt Benckiser Group Plc - Overview
Exhibit 174: Reckitt Benckiser Group Plc - Business segments
Exhibit 175: Reckitt Benckiser Group Plc - Key offerings
Exhibit 176: Reckitt Benckiser Group Plc - Segment focus
12.17 Sanofi SA
Exhibit 177: Sanofi SA - Overview
Exhibit 178: Sanofi SA - Business segments
Exhibit 179: Sanofi SA - Key news
Exhibit 180: Sanofi SA - Key offerings
Exhibit 181: Sanofi SA - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations